Cardiovascular effects of donepezil in patients with dementia

A.T. McLaren; J. Allen; A. Murray; C.G. Ballard; R.A. Kenny

doi:10.1159/000068781

Cardiovascular effects of donepezil in patients with dementia

A.T. McLaren, J. Allen, A. Murray, C.G. Ballard, R.A. Kenny

Research output: Contribution to journal › Article › peer-review

45 Citations (Scopus)

Abstract

Heart rate variability is used to assess cardiovascular autonomic function. The cholinesterase inhibitor donepezil potentially affects parasympathetic activity. Twenty participants with Alzheimer’s disease or dementia with Lewy bodies were treated with donepezil in a pilot study. Power spectral analysis was used to analyse 5 min of beat-to-beat RR interval data in 15 cases. Heart rate variability was significantly reduced following treatment with donepezil; mainly for high frequency (median changed from 581 to 78 ms2; p = 0.001) but also for total power (median changed from 1,563 to 844 ms2; p = 0.047). Donepezil may adversely influence cardiovascular autonomic control. These results indicate the need for larger controlled trials to further investigate the cardiovascular effects of donepezil.

Original language	English
Pages (from-to)	183-188
Number of pages	6
Journal	Dementia and Geriatric Cognitive Disorders
Volume	15
DOIs	https://doi.org/10.1159/000068781
Publication status	Published - 2003
Externally published	Yes

Keywords

donepezil
Cholinesterase inhibitors
Heart rate variability
Power spectral analysis
Autonomic nervous system
Falls
Syncope

Access to Document

10.1159/000068781

Cite this

@article{c69eb928c40141acb366c89748565e57,

title = "Cardiovascular effects of donepezil in patients with dementia",

abstract = "Heart rate variability is used to assess cardiovascular autonomic function. The cholinesterase inhibitor donepezil potentially affects parasympathetic activity. Twenty participants with Alzheimer{\textquoteright}s disease or dementia with Lewy bodies were treated with donepezil in a pilot study. Power spectral analysis was used to analyse 5 min of beat-to-beat RR interval data in 15 cases. Heart rate variability was significantly reduced following treatment with donepezil; mainly for high frequency (median changed from 581 to 78 ms2; p = 0.001) but also for total power (median changed from 1,563 to 844 ms2; p = 0.047). Donepezil may adversely influence cardiovascular autonomic control. These results indicate the need for larger controlled trials to further investigate the cardiovascular effects of donepezil.",

keywords = "donepezil, Cholinesterase inhibitors, Heart rate variability, Power spectral analysis, Autonomic nervous system, Falls, Syncope",

author = "A.T. McLaren and J. Allen and A. Murray and C.G. Ballard and R.A. Kenny",

year = "2003",

doi = "10.1159/000068781",

language = "English",

volume = "15",

pages = "183--188",

journal = "Dementia and Geriatric Cognitive Disorders",

issn = "1421-9824",

publisher = "Karger Publishers",

}

TY - JOUR

T1 - Cardiovascular effects of donepezil in patients with dementia

AU - McLaren, A.T.

AU - Allen, J.

AU - Murray, A.

AU - Ballard, C.G.

AU - Kenny, R.A.

PY - 2003

Y1 - 2003

N2 - Heart rate variability is used to assess cardiovascular autonomic function. The cholinesterase inhibitor donepezil potentially affects parasympathetic activity. Twenty participants with Alzheimer’s disease or dementia with Lewy bodies were treated with donepezil in a pilot study. Power spectral analysis was used to analyse 5 min of beat-to-beat RR interval data in 15 cases. Heart rate variability was significantly reduced following treatment with donepezil; mainly for high frequency (median changed from 581 to 78 ms2; p = 0.001) but also for total power (median changed from 1,563 to 844 ms2; p = 0.047). Donepezil may adversely influence cardiovascular autonomic control. These results indicate the need for larger controlled trials to further investigate the cardiovascular effects of donepezil.

AB - Heart rate variability is used to assess cardiovascular autonomic function. The cholinesterase inhibitor donepezil potentially affects parasympathetic activity. Twenty participants with Alzheimer’s disease or dementia with Lewy bodies were treated with donepezil in a pilot study. Power spectral analysis was used to analyse 5 min of beat-to-beat RR interval data in 15 cases. Heart rate variability was significantly reduced following treatment with donepezil; mainly for high frequency (median changed from 581 to 78 ms2; p = 0.001) but also for total power (median changed from 1,563 to 844 ms2; p = 0.047). Donepezil may adversely influence cardiovascular autonomic control. These results indicate the need for larger controlled trials to further investigate the cardiovascular effects of donepezil.

KW - donepezil

KW - Cholinesterase inhibitors

KW - Heart rate variability

KW - Power spectral analysis

KW - Autonomic nervous system

KW - Falls

KW - Syncope

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-0346319008&partnerID=MN8TOARS

U2 - 10.1159/000068781

DO - 10.1159/000068781

M3 - Article

SN - 1421-9824

VL - 15

SP - 183

EP - 188

JO - Dementia and Geriatric Cognitive Disorders

JF - Dementia and Geriatric Cognitive Disorders

ER -

Cardiovascular effects of donepezil in patients with dementia

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this